サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1510745

欧州の経皮ドラッグデリバリーシステム市場：2030年予測-地域別分析：タイプ、用途、流通チャネル別

Europe Transdermal Drug Delivery System Market Forecast to 2030 - Regional Analysis - by Type, Application, and Distribution Channel

出版日
ページ情報
英文 120 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
欧州の経皮ドラッグデリバリーシステム市場：2030年予測-地域別分析：タイプ、用途、流通チャネル別
出版日: 2024年05月07日
発行: The Insight Partners
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の経皮ドラッグデリバリーシステム市場は、2022年の104億3,386万米ドルから2030年には144億2,286万米ドルに成長すると予測されています。2022～2030年のCAGRは4.1%と推定されます。

非侵襲ドラッグデリバリーデバイスへの需要の高まりが欧州の経皮ドラッグデリバリーシステム市場を後押し

筋肉内投与、静脈内投与、直腸投与といった従来のドラッグデリバリー技術は、主に痛みや複雑さが伴うため、特定の患者層には好まれていないです。医療とドラッグデリバリー技術の進歩により、非侵襲的ドラッグデリバリーシステムは、従来の注射による薬剤投与と競合するようになりました。非侵襲的ドラッグデリバリーシステムには、経口薬、局所薬、経皮吸収薬（デバイスによる浸透促進）、経皮吸収薬、経眼膜薬、経粘膜薬、吸入薬による肺胞膜薬などがあります。経皮ドラッグデリバリーは、経口投与に比べて多くの点で有利です。特に、経皮投与は、薬剤を衝動的に代謝する肝臓の初回通過機構を回避できます。

さらに、経皮投与は皮下注射ほど痛みを伴わず、この経路では危険な医療廃棄物も出ず、特に発展途上国や低開発諸国でよく見られる注射針の再使用による疾病伝播のリスクもないです。さらに、非侵襲的な経皮ドラッグデリバリーシステムは投与スケジュールが簡略化され、薬剤の自己投与が可能です。非侵襲的に薬剤を投与する場合、痛みを伴うことが少ないか全くないため、患者のコンプライアンスははるかに高くなります。従って、この経路はドラッグデリバリーの好ましいモードと考えられています。さらに、非侵襲的ドラッグデリバリーシステムは、患者による薬剤の自己投与のため、臨床使用コストを大幅に削減することができます。このように、経皮ドラッグデリバリーシステムによって促進される非侵襲的な薬剤送達に関連する利点が、市場成長の原動力となっています。

欧州の経皮ドラッグデリバリーシステム市場概要

欧州の経皮ドラッグデリバリーシステム市場は、英国、フランス、ドイツ、スペイン、イタリア、その他の欧州に区分されます。2022年には、ドイツが欧州の経皮ドラッグデリバリーシステム市場で最大のシェアを占めました。同市場は、疼痛管理のニーズの高まりと、同地域における心血管疾患の有病率の増加により、大幅な成長が見込まれています。心不全、心筋梗塞、冠動脈性心疾患、炎症性心疾患などの心血管疾患は、同地域で最も広範な健康問題を占めています。ドイツは、医療医療セグメントで同国を最前線に導く技術の進歩で知られています。2021年に国立生物工学情報センター（NCBI）で発表された研究によると、心血管系疾患の有病率は東ドイツで高いことが多いです。同国では近年、市場関係者による技術革新も進んでいます。2023年5月、バイオネクストソリューションズ社は、パーキンソン病治療用にデザインされた経皮ロチゴチンパッチの薬剤吸収比較試験を進めるための政府承認を取得しました。同社は北米と欧州に研究開発拠点を有し、ドイツを中心に事業を展開しており、現在、欧州市場向けの医療製品の薬事承認と商業化を進めています。

2019年3月、LTS Lohmann Therapie-Systeme AGとLEO Pharma A/Sは共同で、乾癬の局所皮内治療のためのマイクロアレイパッチの臨床試験を開始しました。

ドイツは医療製品やサービスを輸出する主要国のひとつでもあります。加えて、技術的進歩という資産が、品質、安全性、信頼性の国際基準を定めています。さらに、あらゆる健康・医療セグメントにおけるドイツのメーカーやサービスプロバイダーは、医療のイノベーションを提供することで、海外の顧客やパートナーを魅了しています。このような経皮パッチの開拓は、ドイツの経皮ドラッグデリバリーシステム市場の成長を後押ししています。

欧州の経皮ドラッグデリバリーシステム市場の収益と2030年までの予測（金額）

欧州の経皮ドラッグデリバリーシステム市場のセグメンテーション

欧州の経皮ドラッグデリバリーシステム市場は、タイプ、用途、流通チャネル、国に区分されます。

タイプ別では、欧州の経皮ドラッグデリバリーシステム市場は、経皮パッチ、経皮ゲル、経皮スプレー、その他に区分されます。2022年の欧州の経皮ドラッグデリバリーシステム市場では、経皮ゲルセグメントが最大のシェアを占めています。経皮パッチはさらに、薬剤接着パッチ、マトリックスパッチ、リザーバー膜パッチ、蒸気パッチに細分化されます。

用途別では、欧州の経皮ドラッグデリバリーシステム市場は、心血管疾患、中枢神経障害、疼痛管理、ホルモン用途、その他の用途に分類されます。疼痛管理セグメントは、2022年の欧州の経皮ドラッグデリバリーシステム市場で最大のシェアを占めました。疼痛管理はさらにオピオイドと非オピオイドに細分化されます。ホルモン用途はさらに、経皮エストロゲン＆プロゲステロン療法とテストステロン補充に細分化されます。

流通チャネル別では、欧州の経皮ドラッグデリバリーシステム市場は病院薬局、小売薬局、オンライン薬局、その他に区分されます。2022年の欧州の経皮ドラッグデリバリーシステム市場では、病院薬局セグメントが最大のシェアを占めています。

国別に見ると、欧州の経皮ドラッグデリバリーシステム市場は、英国、フランス、ドイツ、スペイン、イタリア、その他の欧州に分類されます。2022年の欧州の経皮ドラッグデリバリーシステム市場はドイツが独占しています。

Boehringer Ingelheim International GmbH、GSK Plc、Hisamitsu Pharmaceutical Co Inc、Johnson & Johnson、Lavipharm SA、Luye Pharma Group Ltd、Novartis AG、UCB SA、Viatris Incは、欧州の経皮ドラッグデリバリーシステム市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブ概要

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の経皮ドラッグデリバリーシステム市場-主要産業力学

  • 市場促進要因
    • 慢性疾患の有病率の増加
    • 非侵襲ドラッグデリバリーデバイスへの需要の高まり
    • 薬剤の自己投与に対する高い需要
  • 市場抑制要因
    • 経皮ドラッグデリバリーシステムの副作用とリコール
  • 市場機会
    • スマートパッチと3Dプリントパッチの進歩
  • 今後の動向
    • メーカーによる戦略的取り組み
  • 影響分析

第5章 経皮ドラッグデリバリーシステム市場-欧州市場分析

  • 経皮ドラッグデリバリーシステムの欧州市場売上高、2022～2030年

第6章 経皮のドラッグデリバリーシステムの欧州市場-2030年までの収益と予測：タイプ別

  • イントロダクション
  • 欧州の経皮ドラッグデリバリーシステム市場：2022年・2030年、タイプ別売上高シェア（%）
  • 経皮パッチ
  • 経皮ゲル
  • 経皮スプレー
  • その他

第7章 欧州の経皮ドラッグデリバリーシステム市場：2030年までの収益と予測：用途別

  • イントロダクション
  • 欧州の経皮ドラッグデリバリーシステム市場：2022年・2030年、用途別売上高シェア（%）
  • 心血管疾患
  • 中枢神経系疾患
  • 疼痛管理
  • ホルモン用途
  • その他

第8章 欧州の経皮ドラッグデリバリーシステム市場：2030年までの収益と予測：流通チャネル別

  • イントロダクション
  • 欧州の経皮ドラッグデリバリーシステム市場：2022年・2030年、流通チャネル別売上高シェア（%）
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第9章 欧州の経皮ドラッグデリバリーシステム市場：2030年までの収益と予測：国別分析

  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他の欧州

第10章 経皮ドラッグデリバリーシステム市場業界情勢

  • イントロダクション
  • 経皮ドラッグデリバリーシステム市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Novartis AG
  • Johnson & Johnson
  • GSK Plc
  • Viatris Inc
  • Boehringer Ingelheim International GmbH
  • Hisamitsu Pharmaceutical Co Inc
  • Luye Pharma Group Ltd
  • Lavipharm SA
  • UCB SA

第12章 付録

図表

List Of Tables

  • Table 1. Europe Transdermal Drug Delivery System Market Segmentation
  • Table 2. Germany: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Germany: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Germany: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Germany: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Germany: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Germany: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. France: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. France: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. France: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. France: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. France: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. France: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. UK: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. UK: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. UK: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. UK: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. UK: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. UK: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Italy: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Italy: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Italy: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Italy: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Italy: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Spain: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Spain: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Spain: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Spain: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Spain: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Spain: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Europe: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Rest of Europe: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Europe: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Europe: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Europe: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Europe: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 39. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 40. Glossary of Terms, Europe Transdermal Drug Delivery System Market

List Of Figures

  • Figure 1. Europe Transdermal Drug Delivery System Market Segmentation, By Country
  • Figure 2. Europe Transdermal Drug Delivery System Market: Key Industry Dynamics
  • Figure 3. Europe Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Europe Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 6. Transdermal Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Drug-in-Adhesive Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Matrix Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Reservoir Membrane Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Vapor Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Transdermal Gels: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Transdermal Sprays: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Europe Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 15. Cardiovascular Diseases: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Central Nervous System Disorders: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Pain Management: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Non-Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Hormonal Applications: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Transdermal Estrogen & Progesterone Therapy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Testosterone Replacement: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Other Application: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Europe Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 25. Hospital Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Retail Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Online Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. Europe Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 31. Germany: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. France: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. UK: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Italy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Spain: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Rest of Europe: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Growth Strategies in the Transdermal Drug Delivery System Market
目次
Product Code: TIPRE00013279

The Europe transdermal drug delivery system market is expected to grow from US$ 10,433.86 million in 2022 to US$ 14,422.86 million by 2030. It is estimated to register a CAGR of 4.1% from 2022 to 2030.

Growing Demand for Noninvasive Drug Delivery Devices Fuels Europe Transdermal Drug Delivery System Market

Traditional drug delivery techniques such as intramuscular, intravenous, and rectal drug administration are not preferred by certain patient populations mainly due to the pain and complexities associated with them. With the improvements in medical science and definite drug delivery technologies, noninvasive drug delivery systems are now set to compete with the traditional method of injectable route of drug administration. The noninvasive drug delivery systems include drug delivery via oral; topical; transdermal-active (device-aided enhanced penetration) and transdermal-passive; and transocular membrane, transmucosal membrane, and alveolar membrane from inhaled medication. Transdermal drug delivery is advantageous in many ways over the oral route of administration. In particular, it evades the first-pass mechanism of the liver, which can otherwise impulsively metabolize drugs.

Further, transdermal delivery is not as painful as hypodermic injections, and this route leads to no dangerous medical waste and poses no risk of disease transmission by needle reuse, which is especially common in developing and under-developed countries. In addition, a noninvasive transdermal drug delivery system has simplified dosing schedules, and the drugs can be self-administered. Patient compliance is much higher when drugs are administrated noninvasively due to low or no pain involved. Therefore, this route is considered a preferred mode of drug delivery. Moreover, a non-invasive drug delivery system can significantly reduce the cost of clinical use because of the self-administration of the drugs by the patients. Thus, the advantages associated with a noninvasive drug delivery facilitated by transdermal drug delivery systems drive the market growth.

Europe Transdermal Drug Delivery System Market Overview

The Europe transdermal drug delivery system market is segmented into the UK, France, Germany, Spain, Italy, and the Rest of Europe. In 2022, the Germany held the largest share of the Europe transdermal drug delivery system market. The market is expected to grow significantly owing to the growing need for pain management and the increasing prevalence of cardiovascular diseases in the region. Cardiovascular diseases such as heart failure, myocardial infarction, coronary cardiac disease, and inflammatory heart disease account for the broadest health problems in the region. Germany is known for its advancement in technology that helps lead the country to the forefront in the medical and healthcare sectors. According to a study published in 2021 in the National Center for Biotechnology Information (NCBI), cardiovascular disease prevalence is often higher in East Germany. The country has also witnessed increasing innovations through market players in recent years. In May 2023, BioNxt Solutions Inc. received government approval to proceed with a comparative drug absorption study for a transdermal Rotigotine patch designed to treat Parkinson's disease. The company has R&D operations in North America and Europe, with an operational focus in Germany, and is currently undergoing regulatory approval and commercialization of medical products for European markets.

In March 2019, LTS Lohmann Therapie-Systeme AG and LEO Pharma A/S together started a clinical trial of microarray patches for the local intradermal treatment of psoriasis.

Germany is also among the primary countries that export healthcare products and services. In addition, the asset of technological advancement has set international standards for quality, safety, and reliability. Moreover, the German manufacturers and service providers in all health and medical segments fascinate foreign customers and partners by delivering healthcare innovation. Such developments in transdermal patches fuel the growth of the transdermal drug delivery system market in Germany.

Europe Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)

Europe Transdermal Drug Delivery System Market Segmentation

The Europe transdermal drug delivery system market is segmented into type, application, distribution channel, and country.

Based on type, the Europe transdermal drug delivery system market is segmented into transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal gel segment held the largest share of the Europe transdermal drug delivery system market in 2022. The transdermal patches is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and vapor patches.

In terms of application, the Europe transdermal drug delivery system market is categorized into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The pain management segment held the largest share of the Europe transdermal drug delivery system market in 2022. The pain management is further sub segmented into opioid and non-opioid. The hormonal applications is further sub segmented into transdermal estrogen & progesterone therapy and testosterone replacement.

By distribution channel, the Europe transdermal drug delivery system market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The hospitals pharmacies segment held the largest share of the Europe transdermal drug delivery system market in 2022.

Based on country, the Europe transdermal drug delivery system market is categorized into the UK, France, Germany, Spain, Italy, and the Rest of Europe. Germany dominated the Europe transdermal drug delivery system market in 2022.

Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Lavipharm SA, Luye Pharma Group Ltd, Novartis AG, UCB SA, and Viatris Inc are some of the leading companies operating in the Europe transdermal drug delivery system market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Transdermal Drug Delivery System Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic Diseases
    • 4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
    • 4.1.3 High Demand for Self-Administration of Drugs
  • 4.2 Market Restraints
    • 4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
  • 4.3 Market Opportunities
    • 4.3.1 Advancements in Smart Patches and 3D-Printed Patches
  • 4.4 Future Trends
    • 4.4.1 Strategic Initiatives by Manufacturers
  • 4.5 Impact Analysis

5. Transdermal Drug Delivery System Market - Europe Market Analysis

  • 5.1 Europe Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030

6. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type

  • 6.1 Overview
  • 6.2 Europe Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
  • 6.3 Transdermal Patches
    • 6.3.1 Overview
    • 6.3.2 Transdermal Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Drug-in-Adhesive Patches
        • 6.3.2.1.1 Overview
        • 6.3.2.1.2 Drug-in-Adhesive Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.2 Matrix Patches
        • 6.3.2.2.1 Overview
        • 6.3.2.2.2 Matrix Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.3 Reservoir Membrane Patches
        • 6.3.2.3.1 Overview
        • 6.3.2.3.2 Reservoir Membrane Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.4 Vapor Patches
        • 6.3.2.4.1 Overview
        • 6.3.2.4.2 Vapor Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Transdermal Gels
    • 6.4.1 Overview
    • 6.4.2 Transdermal Gels: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Transdermal Sprays
    • 6.5.1 Overview
    • 6.5.2 Transdermal Sprays: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Europe Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Overview
    • 7.3.2 Cardiovascular Diseases: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Central Nervous System Disorders
    • 7.4.1 Overview
    • 7.4.2 Central Nervous System Disorders: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Pain Management
    • 7.5.1 Overview
    • 7.5.2 Pain Management: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.1 Opioid
        • 7.5.2.1.1 Overview
        • 7.5.2.1.2 Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.2 Non-Opioid
        • 7.5.2.2.1 Overview
        • 7.5.2.2.2 Non-Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Hormonal Applications
    • 7.6.1 Overview
    • 7.6.2 Hormonal Applications: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 Transdermal Estrogen & Progesterone Therapy
        • 7.6.2.1.1 Overview
        • 7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.2 Testosterone Replacement
        • 7.6.2.2.1 Overview
        • 7.6.2.2.2 Testosterone Replacement: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Application
    • 7.7.1 Overview
    • 7.7.2 Other Application: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 8.1 Overview
  • 8.2 Europe Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 8.3 Hospital Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Hospital Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Retail Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Retail Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Online Pharmacies
    • 8.5.1 Overview
    • 8.5.2 Online Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis

  • 9.1 Europe Transdermal Drug Delivery System Market
    • 9.1.1 Europe Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
      • 9.1.1.1 Germany: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 Germany: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.1.3 Germany: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.1.3.1 Germany: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.1.4 Germany: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.4.1 Germany: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.4.2 Germany: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.5 Germany: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.2 France: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 France: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.2.3 France: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.2.3.1 France: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.2.4 France: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.4.1 France: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.4.2 France: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.5 France: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.3 UK: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 UK: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.3.3 UK: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.3.3.1 UK: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.3.4 UK: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.4.1 UK: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.4.2 UK: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.5 UK: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.4 Italy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Italy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.4.3 Italy: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.4.3.1 Italy: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.4.4 Italy: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.4.1 Italy: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.4.2 Italy: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.5 Italy: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.5 Spain: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Spain: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.5.3 Spain: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.5.3.1 Spain: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.5.4 Spain: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.4.1 Spain: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.4.2 Spain: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.5 Spain: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.6 Rest of Europe: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Europe: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.6.3 Rest of Europe: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.6.3.1 Rest of Europe: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.6.4 Rest of Europe: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.4.1 Rest of Europe: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.4.2 Rest of Europe: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.5 Rest of Europe: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Transdermal Drug Delivery System Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Transdermal Drug Delivery System Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Novartis AG
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 GSK Plc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Viatris Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Boehringer Ingelheim International GmbH
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Hisamitsu Pharmaceutical Co Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Luye Pharma Group Ltd
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Lavipharm SA
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 UCB SA
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms